Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Med.

Sec. Family Medicine and Primary Care

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1568312

This article is part of the Research TopicAI with Insight: Explainable Approaches to Mental Health Screening and Diagnostic Tools in HealthcareView all 6 articles

AlzheimerViT: Harnessing Lightweight Vision Transformer Architecture for Proactive Alzheimer's Screening

Provisionally accepted
  • 1Stanley College of Engineering and Technology for Women, Hyderabad, Telangana, India
  • 2Jazan University, Jizan, Saudi Arabia

The final, formatted version of the article will be published soon.

Alzheimer's is a disease in the human brain characterized by gradual memory loss, confusion, and alterations in behavior. It is a complex and continuously degenerative disorder of the nervous system, which still has early detection and diagnosis as challenges to overcome. The disease causes significant damage in individuals suffering from the disorder as they progressively lose cognitive ability. Its diagnosis and management depend primarily on the ability to diagnose early to initiate proper intervention. Unfortunately, this remains a difficult feat, given the resemblance of early signs of the disease with symptoms associated with normal aging and other disorders involving cognition. While clinical tests have their limitations, brain imaging such as MRI can provide detailed insights into changes in the brain. Deep learning techniques, mainly when applied to MRI data, have proven helpful in the early detection of Alzheimer's Disease.In the proposed study, a lightweight, self-attention-based vision transformer (ViT) is employed to predict Alzheimer's disease using MRI images from the OASIS-3 dataset. Data preprocessing and augmentation techniques have been added to strengthen the model's generalization ability and enhance model performance, which is visualized using Grad-Cam.The proposed model achieves exceptional results with an accuracy of 98.57%, approximate precision of 98.7%, Recall of about 98.47%, and specificity of 98.67%. It also achieves a Kappa Score of 97.2% and an AUC ROC Score of 99%.This paper, along with comprehensive data pre-processing and augmentation, represents one of the major steps toward achieving more robust and clinically applicable models for Alzheimer's disease prediction. The proposed study indicates that deep learning models have the potential to enhance the diagnosis of Alzheimer's disease. By integrating Deep learning techniques with careful data processing, more reliable early detection models can be developed, which in turn leads to better treatment outcomes.

Keywords: Alzheimer's disease, MobileViT, Data augmentation, Disease detection, deep learning

Received: 29 Jan 2025; Accepted: 19 Mar 2025.

Copyright: © 2025 Reddy C, Ahmed, Mohzary, Singh T, Shuaib, Alam and Alnami. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Muhammad Mohzary, Jazan University, Jizan, Saudi Arabia

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.